Home › Cancro della cervice uterina › Virginia › Arlington
Studi clinici su Cancro della cervice uterina a Arlington, VA
16 studi su Cancro della cervice uterina cercano partecipanti presso sedi a Arlington e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
In reclutamentoFase 3
- Inova Schar Cancer Institute ( Site 5045), Fairfax · a 11 mi di distanza
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
In reclutamentoFase 1
- Virginia Cancer Specialists, Fairfax · a 11 mi di distanza
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
In reclutamentoFase 1/2
- NEXT Oncology, Fairfax · a 11 mi di distanza
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
In reclutamentoFase 1
- Virginia Cancer Specialists, Fairfax · a 11 mi di distanza
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
In reclutamentoFase 1
- NEXT Virginia, Fairfax · a 11 mi di distanza
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
In reclutamentoFase 1
- Normunity Investigational Site, Fairfax · a 11 mi di distanza
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- Clinical Trial Site, Fairfax · a 11 mi di distanza
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
In reclutamentoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi di distanza
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
In reclutamento
- Inova Health System, Fairfax · a 11 mi di distanza
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
In reclutamentoFase 1
- NEXT Virginia, Fairfax · a 11 mi di distanza
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · a 11 mi di distanza
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
In reclutamentoFase 1
- Virginia Cancer Specialists, Fairfax · a 11 mi di distanza
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- NEXT, Fairfax · a 11 mi di distanza
Video-Based Patient Navigation to Support Cervical Cancer Screening Among Black Women
In reclutamento
- ISA Associates, Arlington
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
In reclutamentoFase 1
- Dren Investigational Site, Fairfax · a 11 mi di distanza
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
In reclutamentoFase 1/2
- Research Site 102, Fairfax · a 11 mi di distanza
- Research Site 112, Fairfax · a 11 mi di distanza
Studi su Cancro della cervice uterina in altre città
- Houston, TX34 studi
- Nashville, TN19 studi
- New York City, NY19 studi
- Boston, MA18 studi
- Los Angeles, CA16 studi
- San Antonio, TX14 studi
- St. Louis, MO13 studi
- Dallas, TX13 studi
- Orlando, FL12 studi
- Chicago, IL12 studi
- Columbus, OH11 studi
- Atlanta, GA11 studi
Altri studi a Arlington
- Cancro del polmone non a piccole cellule104 studi
- Cancro metastatico53 studi
- Cancro colorettale52 studi
- Cancro (tutti i tipi)48 studi
- Cancro al seno46 studi
- Cancro ovarico46 studi
- Cancro ai polmoni41 studi
- Cancro dell'endometrio39 studi
- Cancro pancreatico33 studi
- Carcinoma a cellule squamose della testa e del collo26 studi
- Carcinoma polmonare a piccole cellule23 studi
- Cancro al seno triplo negativo20 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.